Intelligence

Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored content

Why patenting should not stop at the drug candidate stage – and why coordination between researchers and attorneys is essential for strong protection

Strengthening strategic judgement during uncertainty – exploring the strategic concepts that matter most

Amazon’s entry into the GLP-1 market should be a signal to pharma that it needs to shift focus from molecule to ‘Operating Model’

A spark of creativity can cut through complexity, adding real value and helping to forge true connections with patients

Making launch more effective, precise, cost-effective and agile demands new thinking and new technologies

Industry needs to press the accelerator to adopt AI across functions to
supercharge launch excellence